Skip to main content
SpringerLink
Log in

A Novel System Based on a Poloxamer/ PLGA Blend as a Tetanus Toxoid Delivery Vehicle

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Previous work on the encapsulation of proteins and antigens in poly(lactic-co-glycolic acid) (PLGA) microspheres has led to the conclusion that microencapsulated antigens are frequently inactivated due to their interaction with the polymer. To improve the compatibility of the antigen with the polymer, we have devised a novel microencapsulated system consisting of a blend of PLGA 50:50 and poloxamer 188 (Pluronic® F68) and applied it to the delivery of tetanus antigen.

Methods. Tetanus toxoid was encapsulated in microspheres containing different amounts of poloxamer using an anhydrous procedure based on an oil-in-oil solvent extraction process. The compatibility of the polymers was studied by Fourier transform infrared (FT-IR) spectroscopy. Microspheres were assayed in vitro and in vivo for their ability to deliver active antigen for extended periods of time.

Results. Analysis by FT-IR spectroscopy evidenced the miscibility of both polymers by a hydrogen bonding mechanism. In vitro release studies revealed that microspheres containing poloxamer released anti-genically active TT, in a pulsatile manner, for up to 50 days. In addition, it was observed that the intensity and duration of the pulses were dependent on both poloxamer content and TT loading in the microspheres. The in vivo evaluation of this new system showed that the neutralizing antibodies elicited by the TT encapsulated in poloxamer-PLGA microspheres were considerably higher and more prolonged than those obtained after administration of the aluminum phosphate-adsorbed toxoid.

Conclusions. These results indicate the importance of devising new microencapsulation approaches specially adapted for preserving the activity of protein antigens incorporated within PLGA microspheres.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. I. Esparza, and T. Kissel. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 10:714-720 (1992).

    PubMed  Google Scholar 

  2. B. Gander, C. Thomasin, H. P. Merkle, Y. Men, and G. Corradin. Pulsed tetanus toxoid release from PLGA-microspheres and its relevance for immunogenicity in mice. Proceed. Intern. Symp. Rel. Bioact. Mater. 20:65-66 (1993).

    Google Scholar 

  3. M. J. Alonso, R. K. Gupta, C. Min, G. R. Siber, and R. Langer. Biodegradable microspheres as controlled release tetanus toxoid delivery systems. Vaccine 2:299-306 (1994).

    Google Scholar 

  4. M. J. Alonso, S. Cohen, T. G. Park, R. K. Gupta, G. R. Siber, and R. Langer. Determinants of release of tetanus vaccine from polyester microspheres. Pharm. Res. 10:945-953 (1993).

    PubMed  Google Scholar 

  5. Y. Men, C. Thomasin, H. P. Merkle, B. Gander, and G. Corradin. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine 13:683-689 (1995).

    PubMed  Google Scholar 

  6. C. Thomasin, G. Corradin, Y. Men, H. P. Merkle, and B. Gander. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-coglycolide)-microspheres: importance of polymer degradation and antigen release for immune response. J. Contr. Rel. 41:131-145 (1996).

    Google Scholar 

  7. R. K. Gupta, J. Alroy, M. J. Alonso, R. Langer, and G. R. Siber. Chronic local tissue reactions, long term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers. Vaccine 15:1716-1723 (1997).

    PubMed  Google Scholar 

  8. S. P. Schwendeman, M. Cardamone, M. Branden, A. Klibanov, and R. Langer. Stability of proteins and their delivery from biodegradable polymer microspheres. In S. Cohen and H. Bernstein (eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 1-50.

    Google Scholar 

  9. M. Tobío, and M. J. Alonso. Study of the inactivation process of tetanus toxoid in the presence of PLGA degrading microspheres. S.T. P. Pharma. Sci. 8:303-310 (1998).

    Google Scholar 

  10. A. C. Chang, and R. K. Gupta. Stabilization of tetanus toxoid in poly(D,L-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J. Pharm. Sci. 85:129-132 (1996).

    PubMed  Google Scholar 

  11. S. P. Schwendeman, H. R. Constantino, R. K. Gupta, M. Tobío, A. C. Chang, M. J. Alonso, G. R. Siber, and R. Langer. Strategies for stabilizing tetanus toxoid towards the development of a single-dose tetanus vaccine. In F. Brown (ed.), Developments in Biological Standardization: New Approaches to Stabilization of Vaccine Potency, WHO Series, 1996, pp. 293-306.

  12. R. Wada, S. H. Hyon, and Y. Ykada. Lactic acid oligomer microspheres containing hydrophilic drugs. J. Pharm. Sci. 79:919-924 (1990).

    PubMed  Google Scholar 

  13. E. H. Relyveld. Titrage in vivo des anticorps antidiphteriques et antitetaniques à plusiers niveaux. J. Biol. Stand. 5:45-55 (1977).

    PubMed  Google Scholar 

  14. R. K. Gupta, S. C. Maheshwari, and H. Singh. The titration of tetanus antitoxin. Studies of the sensitivity and reproducibility of the toxin neutralization test. J. Biol. Stand. 13:143-149 (1985).

    PubMed  Google Scholar 

  15. M. J. Alonso, B. Villamayor, M. Tobío, S. Schwendeman, R. K. Gupta, G. R. Siber, and R. Langer. Innovative approaches for the stabilization and controlled release of tetanus vaccine from polyester microspheres. Proceed. Intern. Symp. Rel. Bioact. Mater. 23:825-826 (1996).

    Google Scholar 

  16. T. K. Law, T. L. Whateley, and A. T. Florence. Stabilization of w/o/w multiple emulsions by interfacial complexation of macromolecules and nonionic surfactants. J. Contr. Rel. 3:279-290 (1986).

    Google Scholar 

  17. N. Nihant, C. Schugens, C. Grandfills, R. Jérome, and Ph. Teyssié. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharm. Res. 11:1479-1484 (1994).

    PubMed  Google Scholar 

  18. Ch. Schugens, N. Laruelle, N. Nihant, Ch. Grandfils, R. Jérome, and Ph. Teyssié. Effect of the emulsion stability on the morphology and porosity of semicrystalline poly 1-lactide microparticles prepared by w/o/w double emulsion-evaporation. J. Contr. Rel. 32:161-176 (1994).

    Google Scholar 

  19. A. Zaks, and A. M. Klibanov. The effect of water on enzyme action in organic media. J. Biol. Chem. 263:8017-8021 (1988).

    PubMed  Google Scholar 

  20. M. J. Hageman. Water sorption and solid-state stability of proteins. In T. J. Ahern, and M. C. Manning (eds.), Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation. Plenum Press, New York, 1992, pp. 273-309.

    Google Scholar 

  21. T. G. Park, S. Cohen, and R. Langer. Poly(L-lactic)/Pluronics blends: Characterization of phase separation behaviour, degradation, and morphology and use as protein-releasing matrices. Macromolecules 25:116-122 (1992).

    Google Scholar 

  22. S. Cohen, T. Yoshioka, M. Lucarelli, L. H. Hwang, and R. Langer. Controlled delivery systems for protein based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8:713-720 (1991).

    PubMed  Google Scholar 

  23. H. T. Wang, E. Schmitt, D. R. Flanagan, and R. J. Linhardt. Influence of formulations methods on the in vitro controlled release of protein from poly(ester) microspheres. J. Contr. Rel. 17:23-32 (1991).

    Google Scholar 

  24. R. K. Gupta, B. E. Rost, R. Relyveld, and G. R. Siber. Adjuvant properties of aluminum and calcium compounds. In M. F. Powell, and M. J. Newman (eds.), Vaccine Design: The Subunit and Adjuvant Approach, Plenum Press, New York, 1995, pp. 229-248.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, 15706, Santiago de Compostela, Spain

    María Tobío, Jessica Nolley & María José Alonso

  2. Massachusetts Biologic Laboratories, Boston, Massachusetts, 02130, USA

    Yuyi Guo & James McIver

Authors
  1. María Tobío
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica Nolley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuyi Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James McIver
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. María José Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to María José Alonso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tobío, M., Nolley, J., Guo, Y. et al. A Novel System Based on a Poloxamer/ PLGA Blend as a Tetanus Toxoid Delivery Vehicle. Pharm Res 16, 682–688 (1999). https://doi.org/10.1023/A:1018820507379

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018820507379

Search

Navigation